Metals are essential in medicine for both therapy and diagnosis. We recently created the first metal-chelating nanogel imaging agent, which employed versatile, reproducible chemistry that maximizes chelation stability. Here we demonstrate that our metal chelating crosslinked nanogel technology is a powerful platform by incorporating (64)Cu to obtain PET radiotracers. Polyacrylamide-based nanogels were crosslinked with three different polydentate ligands (DTPA, DOTA, NOTA). NOTA-based nanogels stably retained (64)Cu in mouse serum and accumulated in tumors in vivo as detected by PET/CT imaging. Measurement of radioactivity in major organs ex vivo confirmed this pattern, revealing a high accumulation (12.3% ID/g and 16.6% ID/g) in tumors at 24 and 48 h following administration, with lower accumulation in the liver (8.5% ID/g at 24 h) and spleen (5.5% ID/g). Nanogels accumulated even more efficiently in metastases (29.9% and 30.4% ID/g at 24 and 48 h). These metal-chelating nanogels hold great promise for future application as bimodal PET/MRI agents; chelation of β-emitting radionuclides could enable radiation therapy.
Nucl Med Biol. 2013 Apr;40(3):345-50
[PMID:
23394821]
Cancer Biother Radiopharm. 2008 Apr;23(2):158-71
[PMID:
18454685]
Int J Toxicol. 2005;24 Suppl 2:21-50
[PMID:
16154914]
J Am Chem Soc. 2014 Feb 5;136(5):1706-9
[PMID:
24401138]
Nature. 2008 Apr 3;452(7187):580-9
[PMID:
18385732]
Bioconjug Chem. 2007 Jan-Feb;18(1):77-83
[PMID:
17226959]
Bioconjug Chem. 2010 Apr 21;21(4):715-22
[PMID:
20353170]
Cancer Biother Radiopharm. 2009 Aug;24(4):379-93
[PMID:
19694573]
J Am Chem Soc. 2010 Nov 3;132(43):15351-8
[PMID:
20942456]
Nucl Med Biol. 1993 May;20(4):461-7
[PMID:
8504288]
Angew Chem Int Ed Engl. 2009;48(30):5418-29
[PMID:
19562807]
J Appl Toxicol. 2013 Sep;33(9):940-50
[PMID:
22733552]
Anal Biochem. 1985 Jul;148(1):249-53
[PMID:
4037304]
Biomater Sci. 2013 Oct;1(10):1055-1064
[PMID:
24058728]
Chem Soc Rev. 2006 Jun;35(6):512-23
[PMID:
16729145]
ACS Nano. 2012 Jun 26;6(6):5209-19
[PMID:
22548282]
Eur J Pharm Sci. 2006 Oct 1;29(2):120-9
[PMID:
16904301]
J Drug Target. 2000;8(2):91-105
[PMID:
10852341]
J Nucl Med. 2011 Jul;52(7):1110-8
[PMID:
21680701]
Angew Chem Int Ed Engl. 2014 Jan 3;53(1):156-9
[PMID:
24272951]
Plast Reconstr Surg. 2003 May;111(6):1883-90
[PMID:
12711948]
Bioconjug Chem. 2011 Aug 17;22(8):1729-35
[PMID:
21761921]
J Pharmacol Exp Ther. 1979 Dec;211(3):656-62
[PMID:
512927]
J Nucl Med. 2005 Jul;46(7):1210-8
[PMID:
16000291]
Mol Pharm. 2013 Jun 3;10(6):2190-8
[PMID:
23586421]
ACS Nano. 2011 Feb 22;5(2):738-47
[PMID:
21275414]
Biomacromolecules. 2007 Oct;8(10):3126-34
[PMID:
17880180]
J Mater Chem B Mater Biol Med. 2013 Dec 14;1(46):6359-6364
[PMID:
24505553]
Macromolecules. 2007;40(9):2971-2973
[PMID:
18779874]
Chem Rev. 1999 Sep 8;99(9):2219-34
[PMID:
11749480]
Biomacromolecules. 2014 May 12;15(5):1625-33
[PMID:
24645913]
Mol Pharm. 2008 Jul-Aug;5(4):505-15
[PMID:
18672949]
Bioconjug Chem. 2014 Mar 19;25(3):601-10
[PMID:
24506683]
Biomacromolecules. 2008 Apr;9(4):1329-39
[PMID:
18338840]
Angew Chem Int Ed Engl. 2008;47(45):8568-80
[PMID:
18825758]
J Control Release. 2005 Jul 20;105(3):199-212
[PMID:
15935507]
J Med Chem. 2002 Jan 17;45(2):469-77
[PMID:
11784151]
ACS Nano. 2012 Jul 24;6(7):5880-8
[PMID:
22690722]
Circulation. 2008 Jan 22;117(3):379-87
[PMID:
18158358]
Chem Rev. 1999 Sep 8;99(9):2353-78
[PMID:
11749484]
Biomaterials. 2011 Jun;32(17):4151-60
[PMID:
21367450]
Inorg Chem. 2011 Sep 19;50(18):8946-58
[PMID:
21859074]
Anal Chem. 2012 Aug 7;84(15):6278-87
[PMID:
22624599]
Macromol Rapid Commun. 2013 Apr 12;34(7):562-7
[PMID:
23423755]
Bioconjug Chem. 2013 Feb 20;24(2):196-204
[PMID:
23272904]
Mol Pharm. 2014 Nov 3;11(11):3930-7
[PMID:
24992368]
Theranostics. 2014;4(6):614-28
[PMID:
24723983]
J Thorac Dis. 2013 Aug;5(4):385-92
[PMID:
23991292]
Chem Rev. 1999 Sep 8;99(9):2293-352
[PMID:
11749483]
J Med Chem. 2004 Mar 11;47(6):1465-74
[PMID:
14998334]
J Nucl Med. 2008 Jan;49(1):103-11
[PMID:
18077519]
